Esophageal Self-expandable Metal Stent for Malignant Strictures: a Safety and Efficacy Study

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 2, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2025

Conditions
Oesophageal Cancer
Interventions
DEVICE

Esophageal self-expandable metal stent

The Leufen Esophageal aixstent ® (Leufen Medical GmbH) is indicated for the treatment of malignant esophageal strictures and postoperative stenosis. It is comprised of two components: an implantable metallic stent and the delivery system. After the procedure, the stent remains at the intended location, within the patient while the delivery system is removed.

Trial Locations (1)

3015GD

RECRUITING

Erasmus MC, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER

NCT06364553 - Esophageal Self-expandable Metal Stent for Malignant Strictures: a Safety and Efficacy Study | Biotech Hunter | Biotech Hunter